Trial Profile
Clinical And Economic Impact Of Upfront Plerixafor In Autologous Transplantation.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Filgrastim (Primary) ; Plerixafor (Primary)
- Indications Multiple myeloma; Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 29 Apr 2016 Status changed from active, no longer recruiting to completed.
- 05 Jun 2015 Planned End Date changed from 1 Apr 2015 to 1 Jul 2016, as reported by ClinicalTrials.gov record.
- 05 Jun 2015 Planned primary completion date changed from 1 Apr 2015 to 1 Jul 2015, as reported by ClinicalTrials.gov record.